| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA ME |
| (30) |
Priority: |
27.09.2019 US 201962907231 P
19.12.2019 US 201962950546 P
|
| (43) |
Date of publication of application: |
|
13.07.2022 Bulletin 2022/28 |
| (73) |
Proprietors: |
|
- Collaborations Pharmaceuticals, Inc.
Raleigh, NC 27606 (US)
- Universitätsklinikum Jena
07747 Jena (DE)
|
|
| (72) |
Inventors: |
|
- MAKAROV, Vadim
Moscow, 115035 (RU)
- SCHMIDTKE, Michaela
07745 Jena (DE)
- EKINS, Sean
Fuquay Varina, NC 27526 (US)
|
| (74) |
Representative: Isarpatent |
|
Patent- und Rechtsanwälte Barth
Charles Hassa Peckmann & Partner mbB
Friedrichstrasse 31
80801 München
80801 München (DE) |
| (56) |
References cited: :
US-A1- 2011 065 764
US-A1- 2019 054 068
|
US-A1- 2012 095 002
|
|
| |
|
|
- MAKAROV VADIM A. ET AL: "Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition
of human rhinovirus 2 and coxsackievirus B3 replication", JOURNAL OF ANTIMICROBIAL
CHEMOTHERAPY, vol. 55, no. 4, 1 April 2005 (2005-04-01), GB, pages 483 - 488, XP093060461,
ISSN: 0305-7453, Retrieved from the Internet <URL:https://academic.oup.com/jac/article-pdf/55/4/483/2399776/dki055.pdf>
DOI: 10.1093/jac/dki055
- SCHMIDTKE M ET AL: "New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives
with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant
coxsackievirus B3", ANTIVIRAL RESEARCH, ELSEVIER BV, NL, vol. 81, no. 1, 1 January
2009 (2009-01-01), pages 56 - 63, XP025761847, ISSN: 0166-3542, [retrieved on 20081208],
DOI: 10.1016/J.ANTIVIRAL.2008.09.002
- CHEN YONGSHENG ET AL: "[alpha]Gal-conjugated anti-rhinovirus agents: chemo-enzymatic
syntheses and testing of anti-Gal binding", ROYAL CHEMICAL SOCIETY. JOURNAL. PERKIN
TRANSACTIONS 1, no. 14, 1 January 2001 (2001-01-01), GB, pages 1716 - 1722, XP093060427,
ISSN: 1472-7781, DOI: 10.1039/b100356i
- DATABASE PubChem Compound 3 May 2011 (2011-05-03), ANONYMOUS: "Compound Summary for
CID 51323276", XP055806868, retrieved from NCBI Database accession no. CID 51323276
|
|
